Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.

@article{Borrelli2013BeneficialEO,
  title={Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.},
  author={Francesca Borrelli and Ines Fasolino and Barbara Romano and Raffaele Capasso and Francesco Maria Maiello and Diana Coppola and Pierangelo Orlando and Giovanni Battista and E. Pagano and Vincenzo Di Marzo and Angelo A Izzo},
  journal={Biochemical pharmacology},
  year={2013},
  volume={85 9},
  pages={1306-16}
}
Inflammatory bowel disease (IBD) is an incurable disease which affects millions of people in industrialized countries. Anecdotal and scientific evidence suggests that Cannabis use may have a positive impact in IBD patients. Here, we investigated the effect of cannabigerol (CBG), a non-psychotropic Cannabis-derived cannabinoid, in a murine model of colitis. Colitis was induced in mice by intracolonic administration of dinitrobenzene sulphonic acid (DNBS). Inflammation was assessed by evaluating… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 20 times over the past 90 days. VIEW TWEETS
35 Extracted Citations
59 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 35 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 59 references

Similar Papers

Loading similar papers…